TP53 and Alzheimer disease: We homogenized temporal lobe autopsy samples from AD and age-matched unaffected patients at high dilution (1:50) to avoid artifactual aggregation and measured the oligomerization state of phospho(S15)-p53 in 15,000×g extracts using size-exclusion HPLC.